EATG » Vaccines

Vaccines

HVTN’s large-scale HIV vaccine efficacy trials fully enrolled

SEATTLE, JUNE 21,2019 – The HIV Vaccine Trials Network (HVTN), headquartered at the Fred Hutchinson Cancer Research Center, has fully enrolled its four ongoing large-scale HIV vaccine efficacy trials. The…

VBI Vaccines announces Phase 3 study results for Sci-B-Vac®

VBI Vaccines announces positive top-line results from PROTECT, a pivotal Phase 3 study of Sci-B-Vac® -- Both co-primary endpoints successfully met – including non-inferiority in all adults age ≥18 years,…

The three big studies pushing at the frontiers of HIV prevention

There are an estimated 5000 new HIV transmissions every day. Around 70% of the 37 million people living with HIV globally are in sub-Saharan Africa. Of the 1.8 million new…

Johnson & Johnson announces full enrollment in proof-of-concept efficacy study of Janssen’s investigational HIV preventive vaccine

Phase 2b efficacy study of mosaic-based vaccine successfully enrolls 2,600 women aged 18-35 across five southern African countries NEW BRUNSWICK, NJ, May 29, 2019 – Johnson & Johnson today announced that…

HIV-related factors predict reinforced hepatitis B vaccination success

Certain characteristics and HIV-related factors may help predict whether certain demographics of people with HIV will have an optimal response to reinforced hepatitis B virus vaccination, according to an article…

Trial evaluating experimental hepatitis C vaccine concludes

An experimental vaccine was not found to be effective at preventing chronic hepatitis C virus (HCV) infection in adults, according to results from a clinical trial sponsored by the National…

Monkey-infecting virus may provide part of future HIV vaccine

Simian immunodeficiency virus envelope protein elicits desired anti-HIV antibody response in mice LA JOLLA, CA – A protein from Simian Immunodeficiency Virus (SIV), which can infect monkeys and apes, has…

HIV Vaccine Awareness Day 2019 — May 18

Statement by Anthony S. Fauci, M.D., Director, National Institute of Allergy and Infectious Diseases, and Maureen M. Goodenow, Ph.D., NIH Associate Director for AIDS Research and Director, Office of AIDS…

New findings could lead to improved vaccinations against sexually transmitted infections

In a study published in the Nature Communications, researchers from King's College London have shown how skin vaccination can generate protective CD8 T-cells that are recruited to the genital tissues…

Could an infant’s blood sample help model a better HIV vaccine?

Tracing the evolution of a baby’s special HIV-blocking protein Forward progress sometimes requires a backward glance. A twenty-five-year-old blood sample from an infant infected with HIV could hold clues to…

1 2 3 25